• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于前列腺癌进展中种族差异的贝叶斯分段混合模型。

Bayesian piecewise mixture model for racial disparity in prostate cancer progression.

作者信息

Zhao L, Banerjee M

机构信息

Biostatistics Unit University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor.

Department of Biostatistics University of Michigan, Ann Arbor.

出版信息

Comput Stat Data Anal. 2012 Feb 1;56(2):362-369. doi: 10.1016/j.csda.2011.07.011.

DOI:10.1016/j.csda.2011.07.011
PMID:25540470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4273308/
Abstract

Racial differences in prostate cancer incidence and mortality have been reported. Several authors hypothesize that African Americans have a more rapid growth rate of prostate cancer compared to Caucasians, that manifests in higher recurrence and lower survival rates in the former group. In this paper we propose a Bayesian piecewise mixture model to characterize PSA progression over time in African Americans and Caucasians, using follow-up serial PSA measurements after surgery. Each individual's PSA trajectory is hypothesized to have a latent phase immediately following surgery followed by a rapid increase in PSA indicating regrowth of the tumor. The true time of transition from the latent phase to the rapid growth phase is unknown, and can vary across individuals, suggesting a random change point across individuals. Furthermore, some patients may not experience the latent phase due to the cancer having already spread outside the prostate before undergoing surgery. We propose a two-component mixture model to accommodate patients both with and without a latent phase. Within the framework of this mixture model, patients who do not have a latent phase are allowed to have different rates of PSA rise; patients who have a latent phase are allowed to have different PSA trajectories, represented by subject-specific change points and rates of PSA rise before and after the change point. The proposed Bayesian methodology is implemented using Markov Chain Monte Carlo techniques. Model selection is performed using deviance information criteria based on the observed and complete likelihoods. Finally, we illustrate the methods using a prostate cancer dataset.

摘要

已有报道称前列腺癌的发病率和死亡率存在种族差异。几位作者推测,与白种人相比,非裔美国人的前列腺癌生长速度更快,这表现为前者更高的复发率和更低的生存率。在本文中,我们提出了一种贝叶斯分段混合模型,以利用手术后的随访系列前列腺特异性抗原(PSA)测量值来描述非裔美国人和白种人随时间的PSA进展情况。假设每个个体的PSA轨迹在手术后立即有一个潜伏期,随后PSA迅速升高,表明肿瘤复发。从潜伏期到快速生长阶段的真正转变时间是未知的,并且可能因个体而异,这表明个体间存在随机变化点。此外,一些患者可能由于癌症在手术前已经扩散到前列腺以外而没有经历潜伏期。我们提出了一种双组分混合模型来适应有和没有潜伏期的患者。在这个混合模型的框架内,没有潜伏期的患者被允许有不同的PSA上升速率;有潜伏期的患者被允许有不同的PSA轨迹,由个体特异性变化点以及变化点前后的PSA上升速率表示。所提出的贝叶斯方法使用马尔可夫链蒙特卡罗技术来实现。基于观察到的和完整的似然性,使用偏差信息准则进行模型选择。最后,我们使用一个前列腺癌数据集来说明这些方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd17/4273308/34da2526f2e5/nihms621089f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd17/4273308/cf6fd81c807b/nihms621089f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd17/4273308/34da2526f2e5/nihms621089f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd17/4273308/cf6fd81c807b/nihms621089f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd17/4273308/34da2526f2e5/nihms621089f2.jpg

相似文献

1
Bayesian piecewise mixture model for racial disparity in prostate cancer progression.用于前列腺癌进展中种族差异的贝叶斯分段混合模型。
Comput Stat Data Anal. 2012 Feb 1;56(2):362-369. doi: 10.1016/j.csda.2011.07.011.
2
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers.使用纵向生物标志物的贝叶斯混合分段线性模型评估治疗效果。
Stat Med. 2015 May 10;34(10):1733-46. doi: 10.1002/sim.6445. Epub 2015 Jan 29.
3
Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes.基于非线性纵向生物标志物和事件时间结果的联合模型预测前列腺癌复发时间
Stat Med. 2002 Dec 30;21(24):3897-911. doi: 10.1002/sim.1392.
4
Fitting a linear-linear piecewise growth mixture model with unknown knots: A comparison of two common approaches to inference.拟合带有未知节点的线性-线性分段增长混合模型:两种常见推断方法的比较。
Psychol Methods. 2015 Jun;20(2):259-75. doi: 10.1037/met0000034. Epub 2015 Apr 13.
5
Trajectories of prostate-specific antigen after treatment for prostate cancer.前列腺癌治疗后的前列腺特异性抗原轨迹。
J Investig Med. 2018 Apr;66(4):768-772. doi: 10.1136/jim-2017-000627. Epub 2017 Nov 22.
6
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
7
Detecting Multiple Random Changepoints in Bayesian Piecewise Growth Mixture Models.贝叶斯分段增长混合模型中多个随机变点的检测。
Psychometrika. 2018 Sep;83(3):733-750. doi: 10.1007/s11336-017-9594-5. Epub 2017 Nov 17.
8
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.
9
Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer.用于生化标志物的分层变点模型,通过追踪前列腺癌男性放疗后前列腺特异性抗原系列进行说明。
Ann Epidemiol. 2008 Apr;18(4):270-82. doi: 10.1016/j.annepidem.2007.10.006.
10
Bayesian Comparison of Latent Variable Models: Conditional Versus Marginal Likelihoods.潜变量模型的贝叶斯比较:条件与边际似然。
Psychometrika. 2019 Sep;84(3):802-829. doi: 10.1007/s11336-019-09679-0. Epub 2019 Jul 11.

引用本文的文献

1
Detecting Multiple Random Changepoints in Bayesian Piecewise Growth Mixture Models.贝叶斯分段增长混合模型中多个随机变点的检测。
Psychometrika. 2018 Sep;83(3):733-750. doi: 10.1007/s11336-017-9594-5. Epub 2017 Nov 17.
2
Evaluation of treatment efficacy using a Bayesian mixture piecewise linear model of longitudinal biomarkers.使用纵向生物标志物的贝叶斯混合分段线性模型评估治疗效果。
Stat Med. 2015 May 10;34(10):1733-46. doi: 10.1002/sim.6445. Epub 2015 Jan 29.

本文引用的文献

1
Hierarchical changepoint models for biochemical markers illustrated by tracking postradiotherapy prostate-specific antigen series in men with prostate cancer.用于生化标志物的分层变点模型,通过追踪前列腺癌男性放疗后前列腺特异性抗原系列进行说明。
Ann Epidemiol. 2008 Apr;18(4):270-82. doi: 10.1016/j.annepidem.2007.10.006.
2
Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era.
J Urol. 2003 Dec;170(6 Pt 2):S42-6; discussion S46-7. doi: 10.1097/01.ju.0000094800.63501.15.
3
Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database.根治性前列腺切除术后生化复发的时间趋势:SEARCH数据库的结果
Urology. 2003 Apr;61(4):736-41. doi: 10.1016/s0090-4295(02)02526-8.
4
Should African-American men be tested for prostate carcinoma at an earlier age than white men?非裔美国男性是否应该比白人男性更早接受前列腺癌检测?
Cancer. 1999 Jan 15;85(2):472-7.
5
Follow-up prostate cancer treatments after radical prostatectomy: a population-based study.
J Natl Cancer Inst. 1996 Feb 21;88(3-4):166-73. doi: 10.1093/jnci/88.3-4.166.
6
Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.在平等医疗保健环境下,黑人种族是前列腺癌根治术后复发的不良预后因素。
J Urol. 1996 May;155(5):1667-73.
7
An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.根治性前列腺切除术评估。时间趋势、地理差异及结果。前列腺患者结局研究团队。
JAMA. 1993 May 26;269(20):2633-6. doi: 10.1001/jama.269.20.2633.
8
Change points in the series of T4 counts prior to AIDS.艾滋病出现之前T4细胞计数系列中的变化点。
Biometrics. 1995 Mar;51(1):236-48.
9
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer.前列腺癌放疗后前列腺特异性抗原倍增时间与疾病复发
Cancer. 1994 Jul 15;74(2):670-8. doi: 10.1002/1097-0142(19940715)74:2<670::aid-cncr2820740220>3.0.co;2-8.
10
A statistical method for assessing a threshold in epidemiological studies.
Stat Med. 1991 Mar;10(3):341-9. doi: 10.1002/sim.4780100306.